Truvestments Capital’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-195
Closed -$2.25K 828
2023
Q4
$2.25K Buy
195
+2
+1% +$23 ﹤0.01% 671
2023
Q3
$2.46K Buy
193
+2
+1% +$28 ﹤0.01% 576
2023
Q2
$2.62K Buy
+191
New +$2.74K ﹤0.01% 586
2023
Q1
Sell
-188
Closed -$2.52K 877
2022
Q4
$2.52K Buy
188
+2
+1% +$27 ﹤0.01% 680
2022
Q3
$2K Buy
186
+2
+1% +$35 ﹤0.01% 564
2022
Q2
$4K Buy
+184
New +$3.48K ﹤0.01% 505
2022
Q1
Sell
-182
Closed -$4K 430
2021
Q4
$4K Buy
182
+1
+0.6% +$21 ﹤0.01% 508
2021
Q3
$4K Buy
181
+1
+0.6% +$24 ﹤0.01% 479
2021
Q2
$5K Buy
180
+1
+0.6% +$27 ﹤0.01% 462
2021
Q1
$4K Buy
179
+1
+0.6% +$23 ﹤0.01% 544
2020
Q4
$3K Buy
+178
New +$3.27K ﹤0.01% 529
2020
Q3
Sell
-321
Closed -$8K 479
2020
Q2
$8K Sell
321
-204
-39% -$5.07K 0.01% 405
2020
Q1
$12K Buy
+525
New +$12.8K 0.02% 330
2019
Q4
Sell
-769
Closed -$16K 448
2019
Q3
$16K Sell
769
-3,811
-83% -$104K 0.01% 440
2019
Q2
$146K Buy
4,580
+3,501
+324% +$110K 0.1% 158
2019
Q1
$36K Buy
+1,079
New +$33.6K 0.03% 325
2018
Q3
$85K Buy
+1,986
New +$93.8K 0.04% 281

Other funds holding PAHC

Truvestments Capital's PAHC Position: Q1 2024 in Review

Truvestments Capital sold out of Phibro Animal Health (PAHC) in Q1 2024, closing a stake of 195 shares — an estimated $2.25K sold.

Truvestments Capital first reported a position in PAHC in Q3 2018 and held it in 17 quarters. The position peaked at $146K in Q2 2019. 138 funds tracked by Wall St. Rank hold PAHC as of Q1 2024.

  • Truvestments Capital reported no remaining Phibro Animal Health position as of Q1 2024 after selling out during the quarter.
  • Truvestments Capital sold 195 Phibro Animal Health shares in Q1 2024, an estimated $2.25K.
  • Truvestments Capital first reported a position in Phibro Animal Health in Q3 2018 and held it in 17 quarters.
  • Truvestments Capital's Phibro Animal Health position peaked at $146K in Q2 2019.
  • 138 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2024.

Based on Truvestments Capital's 13F filing for Q1 2024, filed 14 May 2024.